These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4908720)

  • 1. [Study of the action of basic aluminium clofibrate on blood lipids and hemostasis].
    Edmond E; Daver J; Daver M; Blanchard J; Ricoeur M; Cuong TC
    Therapeutique; 1970 Jan; 46(1):55-9. PubMed ID: 4908720
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
    Mann S; Maisenbacher HJ
    Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the therapeutic effect of clofibrate in discontinuous administration].
    Cottet J; Cristol R; Loeper J; Debray J
    Therapie; 1974; 29(5):675-9. PubMed ID: 4618386
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].
    Brusco OJ; Oriozabala MA; Arakaki R
    Prensa Med Argent; 1971 Oct; 58(32):1587-94. PubMed ID: 4943247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hyperlipidemias].
    Sailer S
    Wien Klin Wochenschr; 1971 Oct; 83(39):691-4. PubMed ID: 5165100
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the effect of probucol on blood lipids].
    Giannini SD; Forti N; Ziliotto EE
    Arq Bras Cardiol; 1981 Feb; 36(2):139-42. PubMed ID: 7325835
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
    Sobra J; Heyrovský A; Sulc M; Horáková D
    Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of hyperlipoidaemias].
    Wolfram G
    Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diffusion of lipid fractions through the barrier of cantharidin blisters in hyperlipidemias under conditions of clofibrate and rutinosid interaction].
    Szamer B
    Ann Acad Med Stetin; 1993; 39():87-101. PubMed ID: 8154625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.